Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) manufacturers
|
| | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) Basic information |
| Product Name: | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) | | Synonyms: | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI);2’-Deoxy-N4-ethyl-5-methylcytidine;6H-Purin-6-one, 9-[2-O-acetyl-5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-β-D-arabinofuranosyl]-1,9-dihydro- (ACI) | | CAS: | 25406-43-3 | | MF: | C12H19N3O4 | | MW: | 269.3 | | EINECS: | | | Product Categories: | | | Mol File: | 25406-43-3.mol |  |
| | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) Chemical Properties |
| Boiling point | 469.6±55.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | pka | 14.03±0.60(Predicted) |
| | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) Usage And Synthesis |
| Uses | 2’-Deoxy-N4-ethyl-5-methylcytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | Cytidine, 2'-deoxy-N-ethyl-5-methyl- (8CI,9CI) Preparation Products And Raw materials |
|